C07C 309/27
Containing carboxyl groups bound to the carbon skeleton
Official title: containing carboxyl groups bound to the carbon skeleton
C07C309/27 (Containing carboxyl groups bound to the carbon skeleton) appears on 15 US grants and 14 published applications in this corpus.
Search patents in C07C- Granted patents
- 15
- Published applications
- 14
- Assignees
- 8
- Inventors
- 39
- Latest grant
- 7 Jan 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 3 |
| 2014 | 0 | 0 |
| 2015 | 2 | 2 |
| 2016 | 1 | 1 |
| 2017 | 2 | 1 |
| 2018 | 1 | 1 |
| 2019 | 0 | 1 |
| 2020 | 2 | 1 |
| 2021 | 2 | 1 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for treating and preventing neurodegenerative disorders7 Jan 2025US 12,187,668 B2Alzheon, Inc.
- Salts of an epidermal growth factor receptor kinase inhibitor5 Apr 2022US 11,292,772 B2Celgene CAR LLC
- Compositions and methods for treating and preventing neurodegenerative disorders6 Jul 2021US 11,053,192 B2Alzheon, Inc.
- Compounds for inhibiting the activity of SARS-COV-2 spike glycoprotein15 Jun 2021US 11,034,655 B1
- Compositions and methods for treating and preventing neurodegenerative disorders17 Mar 2020US 10,590,070 B2Alzheon, Inc.
- Radiation-sensitive composition, method for forming pattern and onium salt compound5 Mar 2026US 2026/0063994 A1Jsr Corporation
- Radiation-sensitive composition, pattern formation method, and photo-degradable base9 Jan 2025US 2025/0013150 A1Jsr Corporation
- Compositions and methods for treating and preventing neurodegenerative disorders4 May 2023US 2023/0133465 A1Alzheon, Inc.
- Salts of an epidermal growth factor receptor kinase inhibitor21 Jan 2021US 2021/0017137 A1Celgene CAR LLC
- Compositions and methods for treating and preventing neurodegenerative disorders5 Nov 2020US 2020/0347012 A1Alzheon, Inc.
Most cited
By later US patents
- Bicyclo 2,2,2!octane derivatives15US 5,514,683 AJames Black Foundation Limited · 1996
- Salts of an epidermal growth factor receptor kinase inhibitor9US 9,108,927 B2Celgene Avilomics Research, Inc. · 2015
- Radiation-sensitive composition, and compound8US 9,023,584 B2Jsr Corporation · 2015
- Salts of an epidermal growth factor receptor kinase inhibitor5US 9,540,335 B2Celgene Avilomics Research, Inc. · 2017
- Photoresist composition, compound, and production method thereof4US 9,477,149 B2Jsr Corporation · 2016